Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.26 USD | +1.99% | -2.29% | +1.53% |
05:34pm | Celldex Therapeutics Reports First Patient Dosed in Phase 2 Skin Disorder Study | MT |
May. 06 | Earnings Flash (CLDX) CELLDEX THERAPEUTICS Posts Q1 Revenue $156,000 | MT |
MarketScreener Editorial Features
Wall Street tries to stay in the green | August 22, 2023 at 09:51 am EDT | |
ANALYST RECOMMENDATIONS : Applovin, BAE Systems, Evercore, Jefferies, Target... | August 22, 2023 at 05:28 am EDT | |
Today on Wall Street: Beware the four witches | September 17, 2021 at 06:29 am EDT | |
ANALYST RECOMMENDATIONS : Autoliv, Fortinet, Tesla, Virgin Galactic, WP Carey... | September 17, 2021 at 04:25 am EDT |
- Stock Market
- Equities
- CLDX Stock
- News Celldex Therapeutics, Inc.
- MarketScreener Editorial Features